These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 17761385)

  • 1. Acceptance of and discontinuation rate from erectile dysfunction oral treatment in patients following bilateral nerve-sparing radical prostatectomy.
    Salonia A; Gallina A; Zanni G; Briganti A; Dehò F; Saccà A; Suardi N; Barbieri L; Guazzoni G; Rigatti P; Montorsi F
    Eur Urol; 2008 Mar; 53(3):564-70. PubMed ID: 17761385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of statin therapy on early return of potency after nerve sparing radical retropubic prostatectomy.
    Hong SK; Han BK; Jeong SJ; Byun SS; Lee SE
    J Urol; 2007 Aug; 178(2):613-6. PubMed ID: 17570410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baseline potency in candidates for bilateral nerve-sparing radical retropubic prostatectomy.
    Salonia A; Zanni G; Gallina A; Saccà A; Sangalli M; Naspro R; Briganti A; Farina E; Roscigno M; Dapozzo LF; Rigatti P; Montorsi F
    Eur Urol; 2006 Aug; 50(2):360-5. PubMed ID: 16413666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of nightly versus on-demand vardenafil on recovery of erectile function in men following bilateral nerve-sparing radical prostatectomy.
    Montorsi F; Brock G; Lee J; Shapiro J; Van Poppel H; Graefen M; Stief C
    Eur Urol; 2008 Oct; 54(4):924-31. PubMed ID: 18640769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preserved postoperative penile size correlates well with maintained erectile function after bilateral nerve-sparing radical retropubic prostatectomy.
    Briganti A; Fabbri F; Salonia A; Gallina A; Chun FK; Dehò F; Zanni G; Suardi N; Karakiewicz PI; Rigatti P; Montorsi F
    Eur Urol; 2007 Sep; 52(3):702-7. PubMed ID: 17418936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of combined intracorporal injection and a phosphodiesterase-5 inhibitor therapy for men with a suboptimal response to sildenafil and/or vardenafil monotherapy after radical retropubic prostatectomy.
    Mydlo JH; Viterbo R; Crispen P
    BJU Int; 2005 Apr; 95(6):843-6. PubMed ID: 15794795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term efficacy and compliance of MUSE for erectile dysfunction following radical prostatectomy: SHIM (IIEF-5) analysis.
    Raina R; Agarwal A; Zaramo CE; Ausmundson S; Mansour D; Zippe CD
    Int J Impot Res; 2005; 17(1):86-90. PubMed ID: 15526008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphodiesterase 5 inhibitors for erectile dysfunction.
    Setter SM; Iltz JL; Fincham JE; Campbell RK; Baker DE
    Ann Pharmacother; 2005; 39(7-8):1286-95. PubMed ID: 15941818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erectile dysfunction following nerve-sparing radical retropubic prostatectomy and its treatment with sildenafil.
    Shimizu T; Hisasue S; Sato Y; Kato R; Kobayashi K; Tsukamoto T
    Int J Urol; 2005 Jun; 12(6):552-7. PubMed ID: 15985077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nightly vs on-demand sildenafil for penile rehabilitation after minimally invasive nerve-sparing radical prostatectomy: results of a randomized double-blind trial with placebo.
    Pavlovich CP; Levinson AW; Su LM; Mettee LZ; Feng Z; Bivalacqua TJ; Trock BJ
    BJU Int; 2013 Oct; 112(6):844-51. PubMed ID: 23937708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acetyl-L-carnitine plus propionyl-L-carnitine improve efficacy of sildenafil in treatment of erectile dysfunction after bilateral nerve-sparing radical retropubic prostatectomy.
    Cavallini G; Modenini F; Vitali G; Koverech A
    Urology; 2005 Nov; 66(5):1080-5. PubMed ID: 16286128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of postoperative sexual function after nerve sparing radical retropubic prostatectomy.
    Michl UH; Friedrich MG; Graefen M; Haese A; Heinzer H; Huland H
    J Urol; 2006 Jul; 176(1):227-31. PubMed ID: 16753406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective evaluation of efficacy and compliance with a multistep treatment approach for erectile dysfunction in patients after non-nerve sparing radical prostatectomy.
    Gontero P; Fontana F; Zitella A; Montorsi F; Frea B
    BJU Int; 2005 Feb; 95(3):359-65. PubMed ID: 15679794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of efficacy and satisfaction profile, between penile prosthesis implantation and oral PDE5 inhibitor tadalafil therapy, in men with nerve-sparing radical prostatectomy erectile dysfunction.
    Megas G; Papadopoulos G; Stathouros G; Moschonas D; Gkialas I; Ntoumas K
    BJU Int; 2013 Jul; 112(2):E169-76. PubMed ID: 23253640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of erectile dysfunction after radical retropubic prostatectomy with PDE5 inhibitor].
    Jin W; Huang YR
    Zhonghua Nan Ke Xue; 2005 Sep; 11(9):708-12. PubMed ID: 16209216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of switching phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction: results from the Erectile Dysfunction Observational Study.
    Hatzichristou D; Haro JM; Martin-Morales A; von Keitz A; Riley A; Bertsch J; Belger M; Wolka AM; Beardsworth A;
    Int J Clin Pract; 2007 Nov; 61(11):1850-62. PubMed ID: 17850306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparable efficacy of once-daily versus on-demand vardenafil in men with mild-to-moderate erectile dysfunction: findings of the RESTORE study.
    Zumbé J; Porst H; Sommer F; Grohmann W; Beneke M; Ulbrich E
    Eur Urol; 2008 Jul; 54(1):204-10. PubMed ID: 18395326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term intracavernous therapy responders can potentially switch to sildenafil citrate after radical prostatectomy.
    Raina R; Lakin MM; Agarwal A; Ausmundson S; Montague DK; Zippe CD
    Urology; 2004 Mar; 63(3):532-7; discussion 538. PubMed ID: 15028452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug Insight: oral phosphodiesterase type 5 inhibitors for erectile dysfunction.
    Briganti A; Salonia A; Gallina A; Saccà A; Montorsi P; Rigatti P; Montorsi F
    Nat Clin Pract Urol; 2005 May; 2(5):239-47. PubMed ID: 16474835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recovery of erectile function after nerve-sparing radical prostatectomy: improvement with nightly low-dose sildenafil.
    Bannowsky A; Schulze H; van der Horst C; Hautmann S; Jünemann KP
    BJU Int; 2008 May; 101(10):1279-83. PubMed ID: 18284406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.